Biotricity Statistics
Total Valuation
Biotricity has a market cap or net worth of 2.23 million. The enterprise value is 30.82 million.
| Market Cap | 2.23M |
| Enterprise Value | 30.82M |
Important Dates
The last earnings date was Friday, June 26, 2026.
| Earnings Date | Jun 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biotricity has 20.24 million shares outstanding. The number of shares has increased by 26.85% in one year.
| Current Share Class | 20.07M |
| Shares Outstanding | 20.24M |
| Shares Change (YoY) | +26.85% |
| Shares Change (QoQ) | +3.54% |
| Owned by Insiders (%) | 10.01% |
| Owned by Institutions (%) | 0.33% |
| Float | 17.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| PB Ratio | -0.07 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.93 |
| EV / EBITDA | 13.26 |
| EV / EBIT | 18.22 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.16
| Current Ratio | 0.16 |
| Quick Ratio | 0.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | 11.64 |
| Debt / FCF | -37.64 |
| Interest Coverage | 0.41 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 17.49% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -5.51% |
| Weighted Average Cost of Capital (WACC) | 11.88% |
| Revenue Per Employee | 347,788 |
| Profits Per Employee | -68,010 |
| Employee Count | 46 |
| Asset Turnover | 2.65 |
| Inventory Turnover | 2.11 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.78% in the last 52 weeks. The beta is 1.15, so Biotricity's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | -78.78% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.29 |
| Relative Strength Index (RSI) | 40.08 |
| Average Volume (20 Days) | 28,025 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.61 |
Income Statement
In the last 12 months, Biotricity had revenue of 16.00 million and -3.13 million in losses. Loss per share was -0.11.
| Revenue | 16.00M |
| Gross Profit | 12.95M |
| Operating Income | 1.69M |
| Pretax Income | -2.40M |
| Net Income | -3.13M |
| EBITDA | 1.70M |
| EBIT | 1.69M |
| Loss Per Share | -0.11 |
Balance Sheet
The company has 1.58 million in cash and 27.06 million in debt, with a net cash position of -25.48 million or -1.26 per share.
| Cash & Cash Equivalents | 1.58M |
| Total Debt | 27.06M |
| Net Cash | -25.48M |
| Net Cash Per Share | -1.26 |
| Equity (Book Value) | -31.57M |
| Book Value Per Share | -1.21 |
| Working Capital | -31.28M |
Cash Flow
| Operating Cash Flow | -718,955 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 5,953 |
| Net Borrowing | 781,769 |
| Free Cash Flow | -718,955 |
| FCF Per Share | -0.04 |
Margins
Gross margin is 80.94%, with operating and profit margins of 10.57% and -15.03%.
| Gross Margin | 80.94% |
| Operating Margin | 10.57% |
| Pretax Margin | -15.03% |
| Profit Margin | -15.03% |
| EBITDA Margin | 10.61% |
| EBIT Margin | 10.57% |
| FCF Margin | n/a |
Dividends & Yields
Biotricity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.85% |
| Shareholder Yield | -26.85% |
| Earnings Yield | -140.55% |
| FCF Yield | -32.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 3, 2023. It was a reverse split with a ratio of 0.1666667.
| Last Split Date | Jul 3, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1666667 |
Scores
Biotricity has an Altman Z-Score of -33.25 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -33.25 |
| Piotroski F-Score | 5 |